View in EDS HTML Full Text PDF Full Text

Randomized Phase 2 Study Comparing Pathological Responses of Resected Colorectal Cancer Metastases after Bevacizumab with mFOLFOX6 or FOLFIRI (BEV-ONCO Trial).

Saved in:
Bibliographic Details
Title: Randomized Phase 2 Study Comparing Pathological Responses of Resected Colorectal Cancer Metastases after Bevacizumab with mFOLFOX6 or FOLFIRI (BEV-ONCO Trial).
Authors: Baldin P; Pathology Department, Cliniques Universitaires Saint Luc (UCL)-Université Catholique de Louvain, 1200 Bruxelles, Belgium., Carrasco J; Department of Medical Oncology, GHdC-Grad Hopital de Charleroi-Site Notre Dame, 6000 Charleroi, Belgium., Beniuga G; Pathology Department, Institut de Pathologie et Génétique, 6041 Gosselies, Belgium., Jouret-Mourin A; Pathology Department, Cliniques Universitaires Saint Luc (UCL)-Université Catholique de Louvain, 1200 Bruxelles, Belgium.; Pathology Department, Institut de Pathologie et Génétique, 6041 Gosselies, Belgium., Demolin G; Gastroenterology Department, Clinique CHC MonLégia, 4000 Liège, Belgium., Roland S; Gastroenterology Department, CHIREC-Hôpital Delta, 1160 Auderghem, Belgium., D'Hondt L; Oncology Department, CHU-UCL-Namur, Site Godinne, 5530 Yvoir, Belgium., Vergauwe P; Gastroenterology Department, AZ Groeninge Hospital, 3220 Kortrijk, Belgium., Van Daele D; Gastroenterology Department, CHU de Liège, 4000 Liège, Belgium., Mailleux M; Medical Oncology, Clinique Saint-Luc Bouge, 5000 Namur, Belgium., Sinapi I; Department of Medical Oncology, GHdC-Grad Hopital de Charleroi-Site Notre Dame, 6000 Charleroi, Belgium., De Cuyper A; Department of Medical Oncology, Cliniques Universitaires Saint Luc (UCL)-Université Catholique de Louvain, 1200 Bruxelles, Belgium., Blétard N; Pathology Department, Clinique CHC MonLégia, 4000 Liège, Belgium., Massart B; Pathology Department, Clinique CHC MonLégia, 4000 Liège, Belgium., Delos M; Pathology Department, CHU-UCL-Namur, Site Godinne, 5530 Yvoir, Belgium., Castella ML; Colorectal Clinical Research Unit, Institut Roi Albert II, Cliniques Universitaires Saint Luc (UCL)-Université Catholique de Louvain, 1200 Bruxelles, Belgium., van Maanen A; Support Statistique, Institut Roi Albert II, Cliniques Universitaires Saint Luc (UCL)-Université Catholique de Louvain, 1200 Bruxelles, Belgium., Van den Eynde M; Department of Medical Oncology and Gastroenterology, Cliniques Universitaires Saint Luc (UCL)-Université Catholique de Louvain, 1200 Bruxelles, Belgium.
Source: Cancers [Cancers (Basel)] 2022 Feb 24; Vol. 14 (5). Date of Electronic Publication: 2022 Feb 24.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35267491
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Randomized Phase 2 Study Comparing Pathological Responses of Resected Colorectal Cancer Metastases after Bevacizumab with mFOLFOX6 or FOLFIRI (BEV-ONCO Trial).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Baldin+P%22">Baldin P</searchLink>; Pathology Department, Cliniques Universitaires Saint Luc (UCL)-Université Catholique de Louvain, 1200 Bruxelles, Belgium.<br /><searchLink fieldCode="AU" term="%22Carrasco+J%22">Carrasco J</searchLink>; Department of Medical Oncology, GHdC-Grad Hopital de Charleroi-Site Notre Dame, 6000 Charleroi, Belgium.<br /><searchLink fieldCode="AU" term="%22Beniuga+G%22">Beniuga G</searchLink>; Pathology Department, Institut de Pathologie et Génétique, 6041 Gosselies, Belgium.<br /><searchLink fieldCode="AU" term="%22Jouret-Mourin+A%22">Jouret-Mourin A</searchLink>; Pathology Department, Cliniques Universitaires Saint Luc (UCL)-Université Catholique de Louvain, 1200 Bruxelles, Belgium.; Pathology Department, Institut de Pathologie et Génétique, 6041 Gosselies, Belgium.<br /><searchLink fieldCode="AU" term="%22Demolin+G%22">Demolin G</searchLink>; Gastroenterology Department, Clinique CHC MonLégia, 4000 Liège, Belgium.<br /><searchLink fieldCode="AU" term="%22Roland+S%22">Roland S</searchLink>; Gastroenterology Department, CHIREC-Hôpital Delta, 1160 Auderghem, Belgium.<br /><searchLink fieldCode="AU" term="%22D'Hondt+L%22">D'Hondt L</searchLink>; Oncology Department, CHU-UCL-Namur, Site Godinne, 5530 Yvoir, Belgium.<br /><searchLink fieldCode="AU" term="%22Vergauwe+P%22">Vergauwe P</searchLink>; Gastroenterology Department, AZ Groeninge Hospital, 3220 Kortrijk, Belgium.<br /><searchLink fieldCode="AU" term="%22Van+Daele+D%22">Van Daele D</searchLink>; Gastroenterology Department, CHU de Liège, 4000 Liège, Belgium.<br /><searchLink fieldCode="AU" term="%22Mailleux+M%22">Mailleux M</searchLink>; Medical Oncology, Clinique Saint-Luc Bouge, 5000 Namur, Belgium.<br /><searchLink fieldCode="AU" term="%22Sinapi+I%22">Sinapi I</searchLink>; Department of Medical Oncology, GHdC-Grad Hopital de Charleroi-Site Notre Dame, 6000 Charleroi, Belgium.<br /><searchLink fieldCode="AU" term="%22De+Cuyper+A%22">De Cuyper A</searchLink>; Department of Medical Oncology, Cliniques Universitaires Saint Luc (UCL)-Université Catholique de Louvain, 1200 Bruxelles, Belgium.<br /><searchLink fieldCode="AU" term="%22Blétard+N%22">Blétard N</searchLink>; Pathology Department, Clinique CHC MonLégia, 4000 Liège, Belgium.<br /><searchLink fieldCode="AU" term="%22Massart+B%22">Massart B</searchLink>; Pathology Department, Clinique CHC MonLégia, 4000 Liège, Belgium.<br /><searchLink fieldCode="AU" term="%22Delos+M%22">Delos M</searchLink>; Pathology Department, CHU-UCL-Namur, Site Godinne, 5530 Yvoir, Belgium.<br /><searchLink fieldCode="AU" term="%22Castella+ML%22">Castella ML</searchLink>; Colorectal Clinical Research Unit, Institut Roi Albert II, Cliniques Universitaires Saint Luc (UCL)-Université Catholique de Louvain, 1200 Bruxelles, Belgium.<br /><searchLink fieldCode="AU" term="%22van+Maanen+A%22">van Maanen A</searchLink>; Support Statistique, Institut Roi Albert II, Cliniques Universitaires Saint Luc (UCL)-Université Catholique de Louvain, 1200 Bruxelles, Belgium.<br /><searchLink fieldCode="AU" term="%22Van+den+Eynde+M%22">Van den Eynde M</searchLink>; Department of Medical Oncology and Gastroenterology, Cliniques Universitaires Saint Luc (UCL)-Université Catholique de Louvain, 1200 Bruxelles, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101526829%22">Cancers</searchLink> [Cancers (Basel)] 2022 Feb 24; Vol. 14 (5). <i>Date of Electronic Publication: </i>2022 Feb 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101526829 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2072-6694 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220726694%22">20726694 </searchLink><i>NLM ISO Abbreviation: </i>Cancers (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35267491
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/cancers14051183
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Randomized Phase 2 Study Comparing Pathological Responses of Resected Colorectal Cancer Metastases after Bevacizumab with mFOLFOX6 or FOLFIRI (BEV-ONCO Trial).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Baldin P
      – PersonEntity:
          Name:
            NameFull: Carrasco J
      – PersonEntity:
          Name:
            NameFull: Beniuga G
      – PersonEntity:
          Name:
            NameFull: Jouret-Mourin A
      – PersonEntity:
          Name:
            NameFull: Demolin G
      – PersonEntity:
          Name:
            NameFull: Roland S
      – PersonEntity:
          Name:
            NameFull: D'Hondt L
      – PersonEntity:
          Name:
            NameFull: Vergauwe P
      – PersonEntity:
          Name:
            NameFull: Van Daele D
      – PersonEntity:
          Name:
            NameFull: Mailleux M
      – PersonEntity:
          Name:
            NameFull: Sinapi I
      – PersonEntity:
          Name:
            NameFull: De Cuyper A
      – PersonEntity:
          Name:
            NameFull: Blétard N
      – PersonEntity:
          Name:
            NameFull: Massart B
      – PersonEntity:
          Name:
            NameFull: Delos M
      – PersonEntity:
          Name:
            NameFull: Castella ML
      – PersonEntity:
          Name:
            NameFull: van Maanen A
      – PersonEntity:
          Name:
            NameFull: Van den Eynde M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 02
              Text: 2022 Feb 24
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2072-6694
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Cancers
              Type: main
ResultId 1